RE:RE:New weapon against refractory cancers These big medias won't do an article about a pre-clinical cancer drug. Comparing these with the UQAM little news bulletin is not right.
Wino115 wrote: THIS is why they need to call business press, magazines and pitch the story. It will be taken up. This is obviously the Montreal connections, but US business press is also always looking for stories like this. I hope the PR side, either Leah or the guy who starts the CC's, calls AP, UPI, Bloomberg, WSJ, NYT Science staff, Stat News, etc... and pitches this complelling story.